Skip to main content
Gut logoLink to Gut
. 1998 May;42(5):711–714. doi: 10.1136/gut.42.5.711

Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study

P Karlen 1, D Kornfeld 1, O Brostrom 1, R Lofberg 1, P Persson 1, A Ekbom 1
PMCID: PMC1727094  PMID: 9659169

Abstract

Background—Colonoscopic surveillance is a standard procedure in many patients with long standing, extensive ulcerative colitis (UC), in order to avoid death from colorectal cancer. No conclusive proof of its benefits has been presented however. 
Aims—To evaluate the association between colonoscopic surveillance and colorectal cancer mortality in patients with UC. 
Patients—A population based, nested case control study comprising 142 patients with a definite UC diagnosis, derived from a study population of 4664 patients with UC, was conducted. 
Methods—Colonoscopic surveillance in all patients with UC who had died from colorectal cancer after 1975 was compared with that in controls matched for age, sex, extent, and duration of the disease. Information on colonoscopic surveillance was obtained from the medical records. 
Results—Two of 40 patients with UC and 18 of 102 controls had undergone at least one surveillance colonoscopy (relative risk (RR) 0.29, 95% confidence interval 0.06 to 1.31). Twelve controls but only one patient with UC had undergone two or more surveillance colonoscopies (RR 0.22, 95% confidence interval 0.03 to 1.74), indicating a protective dose response relation. 
Conclusion—Colonoscopic surveillance may be associated with a decreased risk of death from colorectal cancer in patients with long standing UC. 



Keywords: colonoscopic surveillance; colorectal cancer; ulcerative colitis; epidemiology

Full Text

The Full Text of this article is available as a PDF (82.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernstein C. N., Shanahan F., Weinstein W. M. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet. 1994 Jan 8;343(8889):71–74. doi: 10.1016/s0140-6736(94)90813-3. [DOI] [PubMed] [Google Scholar]
  2. Broström O., Löfberg R., Nordenvall B., Ost A., Hellers G. The risk of colorectal cancer in ulcerative colitis. An epidemiologic study. Scand J Gastroenterol. 1987 Dec;22(10):1193–1199. doi: 10.3109/00365528708996463. [DOI] [PubMed] [Google Scholar]
  3. Choi P. M., Nugent F. W., Schoetz D. J., Jr, Silverman M. L., Haggitt R. C. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993 Aug;105(2):418–424. doi: 10.1016/0016-5085(93)90715-o. [DOI] [PubMed] [Google Scholar]
  4. Collins R. H., Jr, Feldman M., Fordtran J. S. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med. 1987 Jun 25;316(26):1654–1658. doi: 10.1056/NEJM198706253162609. [DOI] [PubMed] [Google Scholar]
  5. Connell W. R., Lennard-Jones J. E., Williams C. B., Talbot I. C., Price A. B., Wilkinson K. H. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology. 1994 Oct;107(4):934–944. doi: 10.1016/0016-5085(94)90216-x. [DOI] [PubMed] [Google Scholar]
  6. Devroede G. J., Taylor W. F., Sauer W. G., Jackman R. J., Stickler G. B. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med. 1971 Jul 1;285(1):17–21. doi: 10.1056/NEJM197107012850103. [DOI] [PubMed] [Google Scholar]
  7. EDWARDS F. C., TRUELOVE S. C. THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS. Gut. 1964 Feb;5:1–22. doi: 10.1136/gut.5.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ekbom A., Helmick C., Zack M., Adami H. O. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990 Nov 1;323(18):1228–1233. doi: 10.1056/NEJM199011013231802. [DOI] [PubMed] [Google Scholar]
  9. Ekbom A., Helmick C., Zack M., Adami H. O. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990 Nov 1;323(18):1228–1233. doi: 10.1056/NEJM199011013231802. [DOI] [PubMed] [Google Scholar]
  10. Gage T. P. Managing the cancer risk in chronic ulcerative colitis. A decision-analytic approach. J Clin Gastroenterol. 1986 Feb;8(1):50–57. doi: 10.1097/00004836-198602000-00011. [DOI] [PubMed] [Google Scholar]
  11. Gilat T., Fireman Z., Grossman A., Hacohen D., Kadish U., Ron E., Rozen P., Lilos P. Colorectal cancer in patients with ulcerative colitis. A population study in central Israel. Gastroenterology. 1988 Apr;94(4):870–877. doi: 10.1016/0016-5085(88)90541-0. [DOI] [PubMed] [Google Scholar]
  12. Gyde S. N., Prior P., Allan R. N., Stevens A., Jewell D. P., Truelove S. C., Lofberg R., Brostrom O., Hellers G. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut. 1988 Feb;29(2):206–217. doi: 10.1136/gut.29.2.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gyde S. Screening for colorectal cancer in ulcerative colitis: dubious benefits and high costs. Gut. 1990 Oct;31(10):1089–1092. doi: 10.1136/gut.31.10.1089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kewenter J., Ahlman H., Hultén L. Cancer risk in extensive ulcerative colitis. Ann Surg. 1978 Dec;188(6):824–828. doi: 10.1097/00000658-197812000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Langholz E., Munkholm P., Davidsen M., Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology. 1992 Nov;103(5):1444–1451. doi: 10.1016/0016-5085(92)91163-x. [DOI] [PubMed] [Google Scholar]
  16. Lennard-Jones J. E. Colitic cancer: supervision, surveillance, or surgery? Gastroenterology. 1995 Oct;109(4):1388–1391. doi: 10.1016/0016-5085(95)90604-5. [DOI] [PubMed] [Google Scholar]
  17. Lennard-Jones J. E., Melville D. M., Morson B. C., Ritchie J. K., Williams C. B. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut. 1990 Jul;31(7):800–806. doi: 10.1136/gut.31.7.800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lennard-Jones J. E., Misiewicz J. J., Parrish J. A., Ritchie J. K., Swarbrick E. T., Williams C. B. Prospective study of outpatients with extensive colitis. Lancet. 1974 Jun 1;1(7866):1065–1067. doi: 10.1016/s0140-6736(74)90551-0. [DOI] [PubMed] [Google Scholar]
  19. Lynch D. A., Lobo A. J., Sobala G. M., Dixon M. F., Axon A. T. Failure of colonoscopic surveillance in ulcerative colitis. Gut. 1993 Aug;34(8):1075–1080. doi: 10.1136/gut.34.8.1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Löfberg R., Broström O., Karlén P., Tribukait B., Ost A. Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study. Gastroenterology. 1990 Oct;99(4):1021–1031. doi: 10.1016/0016-5085(90)90622-8. [DOI] [PubMed] [Google Scholar]
  21. Mattsson B., Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol. 1984;23(5):305–313. doi: 10.3109/02841868409136026. [DOI] [PubMed] [Google Scholar]
  22. Moody G. A., Jayanthi V., Probert C. S., Mac Kay H., Mayberry J. F. Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol. 1996 Dec;8(12):1179–1183. doi: 10.1097/00042737-199612000-00009. [DOI] [PubMed] [Google Scholar]
  23. Morson B. C., Pang L. S. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut. 1967 Oct;8(5):423–434. doi: 10.1136/gut.8.5.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nordenvall B., Broström O., Berglund M., Monsen U., Nordenström J., Sörstad J., Hellers G. Incidence of ulcerative colitis in Stockholm County 1955-1979. Scand J Gastroenterol. 1985 Sep;20(7):783–790. doi: 10.3109/00365528509088823. [DOI] [PubMed] [Google Scholar]
  25. Persson P. G., Bernell O., Leijonmarck C. E., Farahmand B. Y., Hellers G., Ahlbom A. Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology. 1996 May;110(5):1339–1345. doi: 10.1053/gast.1996.v110.pm8613037. [DOI] [PubMed] [Google Scholar]
  26. Pinczowski D., Ekbom A., Baron J., Yuen J., Adami H. O. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology. 1994 Jul;107(1):117–120. doi: 10.1016/0016-5085(94)90068-x. [DOI] [PubMed] [Google Scholar]
  27. Prior P., Gyde S. N., Macartney J. C., Thompson H., Waterhouse J. A., Allan R. N. Cancer morbidity in ulcerative colitis. Gut. 1982 Jun;23(6):490–497. doi: 10.1136/gut.23.6.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Provenzale D., Kowdley K. V., Arora S., Wong J. B. Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis. Gastroenterology. 1995 Oct;109(4):1188–1196. doi: 10.1016/0016-5085(95)90578-2. [DOI] [PubMed] [Google Scholar]
  29. Rosenstock E., Farmer R. G., Petras R., Sivak M. V., Jr, Rankin G. B., Sullivan B. H. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology. 1985 Dec;89(6):1342–1346. doi: 10.1016/0016-5085(85)90653-5. [DOI] [PubMed] [Google Scholar]
  30. Rozen P., Baratz M., Fefer F., Gilat T. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology. 1995 May;108(5):1361–1370. doi: 10.1016/0016-5085(95)90683-5. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES